ARCHIVES

BMS, ImClone To Develop New Drug IMC-C225, Targets EGF Receptor.

This article is from The Cancer Letter archive.

Vol. 27 No. 35 | September 28, 2001

Download PDF Visit The Full Archive

Related Articles

Breast Cancer Incidence Goes Up, Most of it in Early, Local Stages

July 11, 1988

Voluntary Organizations: ACS to consider targeting Research In Prostate Cancer

November 1, 1996

UCSF Gets $20 Million For Stem Cell Research Building

February 4, 2011

Aranesp Improved Anemia In MDS In Phase II Trial

September 30, 2005

Feds Set Guidelines For Pharma To Help Patients With Cost Of Drugs, While Steering Clear Of Anti-Kickback Law.

April 28, 2006

US Oncology To Participate In Firm’s Ovarian Cancer Trial.

January 26, 2001